Operates as a platform for the development of novel RNA-based drugs
Sector:
Health Technology
Industry:
Biotechnology
Employees:
21
Frequently Asked Questions
What is Market Cap of PhaseRx, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PhaseRx, Inc. market cap is $643,000.00.
What is the 52-week high for PhaseRx, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PhaseRx, Inc. 52 week high is $0.11 as of September 13, 2025.
What is the 52-week low for PhaseRx, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PhaseRx, Inc. 52 week low is $0.05 as of September 13, 2025.
What is PhaseRx, Inc. stock price today?
PhaseRx, Inc. stock price today is $0.2806.
What was PhaseRx, Inc. stock price yesterday?
PhaseRx, Inc. stock price yesterday was $0.3053.
What is the PE ratio of PhaseRx, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PhaseRx, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of PhaseRx, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PhaseRx, Inc. P/B ratio is -2.1359.
What is PhaseRx, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. PhaseRx, Inc.'s EBITDA is N/A.
What is the 50-day moving average of PhaseRx, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PhaseRx, Inc. 50-day moving average is $0.0688.
